# Silliker Laboratories Group, Inc, Cypress, CA – FDA Inspections

Source: https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067

> Inspection records and compliance data for Silliker Laboratories Group, Inc in Cypress, California. 5 FDA inspections on record, 1 Form 483, last inspected June 30, 2025.

---

## Details

- Name: Silliker Laboratories Group, Inc
- FEI Number: 2020478
- Business Operations: API/FDF ANALYTICAL TESTING
- Address Line 1: 6360 Gateway Dr
- City: Cypress
- State: California
- Zip Code: 90630
- Country Name: United States
- Address: 6360 Gateway Dr, Cypress, California 90630, United States
- Country: United States

## Related Documents

- [483 - Silliker Laboratories Group, Inc - 2025-06-30](https://www.keypedia.com/records/483/silliker-laboratories-group-inc/d625a6b5-76ad-401d-844a-01868249279b) — source: FDA, date: June 30, 2025
- [FDA Inspection 1274266 - Silliker Laboratories Group, Inc - 2025-06-30](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/65cb4ce8-3065-4706-82b4-7d54578fb8d2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2025
- FDA Inspection 1008205 - Silliker Laboratories Group, Inc - 2017-03-07 — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2017
- FDA Inspection 751480 - Silliker Laboratories Group, Inc - 2011-10-12 — classification: No Action Indicated (NAI), source: FDA, date: October 12, 2011
- FDA Inspection 710450 - Silliker Laboratories Group, Inc - 2011-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2011
- [FDA Inspection 663124 - Silliker Laboratories Group, Inc - 2010-05-20](https://www.keypedia.com/records/fda_inspections/silliker-laboratories-group-inc/f1b418c0-88ae-4a80-9dd3-a83dba31e445) — classification: No Action Indicated (NAI), source: FDA, date: May 20, 2010

## Related Companies

- [McGuff Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6)
- [Douglas Glenn Young, M.D.](https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3)
- [Tran-Johnson, Tram K.](https://www.keypedia.com/companies/tran-johnson-tram-k/16da73c1-72e8-4420-a409-9c9e7130b7f5)
- [H J Harkins Company Inc dba Pharma Pac](https://www.keypedia.com/companies/h-j-harkins-company-inc-dba-pharma-pac/f91872b7-2f46-4d40-ae2c-32afca97df2e)
- [Daniel J. DeAngelo, MD](https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c)
- [Patheon Biologics (NJ) LLC](https://www.keypedia.com/companies/patheon-biologics-nj-llc/5d009aee-a952-4eee-a975-1b2bd0559e04)
- [Matrixx Initiatives, Inc.](https://www.keypedia.com/companies/matrixx-initiatives-inc/7fbc68ac-c0d4-4034-af19-6bd954d17e4d)
- [Amryt Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a)
- [Ranbaxy Inc.](https://www.keypedia.com/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481)
- [U.S. Army Medical Research Institute of Infectious Diseases](https://www.keypedia.com/companies/us-army-medical-research-institute-of-infectious-diseases/6d9547df-bbd2-48e8-ba75-d633d911af27)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michael-araneta/c94c95f4-2cda-43f5-a02a-2b5d82fe2c7d)
- [issuing_officer](https://www.keypedia.com/people/ngozi-g-offor/d9d0aa28-6bd1-4427-a712-8716c96b1f3d)